You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206938

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 206938 describes CEFIXIME, which is a drug marketed by Alkem Labs Ltd, Aurobindo Pharma Ltd, Belcher, and Sandoz Inc, and is included in five NDAs. It is available from six suppliers. Additional details are available on the CEFIXIME profile page.

The generic ingredient in CEFIXIME is cefixime. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefixime profile page.
Summary for 206938
Formulation / Manufacturing:see details
Pharmacology for NDA: 206938
Medical Subject Heading (MeSH) Categories for 206938
Suppliers and Packaging for NDA: 206938
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFIXIME cefixime FOR SUSPENSION;ORAL 206938 ANDA NorthStar RxLLC 16714-766 16714-766-01 50 mL in 1 BOTTLE (16714-766-01)
CEFIXIME cefixime FOR SUSPENSION;ORAL 206938 ANDA NorthStar RxLLC 16714-767 16714-767-01 50 mL in 1 BOTTLE (16714-767-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength100MG/5ML
Approval Date:Feb 6, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength200MG/5ML
Approval Date:Feb 6, 2017TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.